Purespring appoints Fredrik Erlandsson as Chief Medical Officer and Peter Mulcahy as Chief People Officer
Appointments of Fredrik and Peter complete build-out of senior team. London— 6 September 2023 Purespring…
Q&A with Julian Hanak
August 2023 When and how did you first get involved with Purespring? Before joining Purespring,…
Purespring Therapeutics appoints Sachin Kelkar as CFO following appointment of Julian Hanak as CEO
Senior leadership team strengthened as Purespring prepares kidney gene therapy programmes for clinical development. London—…
World Kidney Day 2023: Transforming Kidney Disease through Podocyte Gene Therapy
World Kidney Day 2023: Transforming Kidney Disease through Podocyte Gene Therapy Authors: Pille Harrison, Moin…
Purespring Therapeutics to Participate in Upcoming Q4 Conferences
Purespring Therapeutics, a pioneering gene therapy company focused on transforming the treatment of kidney diseases,…
Purespring Therapeutics strengthens scientific leadership with the appointment of Alice Brown as Chief Scientific Officer
Purespring Therapeutics, a pioneering gene therapy company focused on transforming the treatment of kidney diseases,…
Purespring Therapeutics Expands Senior Team with Key Appointments
Appointments include Dr Pille Harrison as VP of Clinical Development, Dr Aoife Waters as Medical…
Purespring Therapeutics and SwanBio Therapeutics announce licensing agreement for use of FunSel screening platform
FunSel is Purespring’s proprietary in-vivo ‘gene search engine’, which allows functional selection of therapeutic factors…
Purespring strengthens senior leadership with appointment of Chief Medical Officer and Chief Development Officer
Purespring Therapeutics, a pioneering gene therapy company focused on transforming the treatment of kidney diseases,…
Purespring appoints new Chief Executive Officer
Purespring Therapeutics (Purespring), a kidney-focused AAV gene therapy company, announces that it is intended to…
EXPLORE
